Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for VERWENDUNG VON VON TUMORINFILTRIERENDEN LYMPHOZYTEN ZUR BEHANDLUNG VON NSCLC PATIENTEN DIE GEGEN ANTI-PD1 ANTIKÖRPERTHERAPIE RESISTENT SIND